Abstract

  1. Guanidinoacetate methyltransferase (GAMT)-deficiency (MIM 601240) is a disease of creatine biosynthesis. Creatine is synthesized in a two-step mechanism from glycine, arginine, and methionine. In the first reaction, guanidinoacetate and ornithine are formed by arginine: glycine aminidinotransferase. In the second reaction, catalyzed by GAMT, S-adenosylmethionine donates the methyl group for formation of creatine from guanidinoacetate.

  2. GAMT-deficiency manifests during the first months of life as developmental delay or arrest. Neurologic symptoms are heterogeneous, including muscular hypotonia and weakness, poor head control, involuntary extrapyramidal movements, epilepsy, and, in older patients, autistic behavior. Abnormal signals in the globus pallidus, as observed on MRI scans, may provide an important clue for diagnosis.

  3. Diagnosis of the disease is based on the demonstration of excessive amounts of guanidinoacetate in body fluids, the deficiency of creatine/phosphocreatine in brain, and the absence of GAMT activity in fibroblasts, lymphocytes, or amniotic fluid cells.

  4. GAMT deficiency is an autosomal recessive disorder. Two GAMT deficiency alleles have been characterized, which account for four of the six alleles in the three patients analyzed so far. The two alleles give rise to transcripts that encode truncated or elongated, presumably nonfunctional polypeptides.

  5. The bulk of creatine is synthesized in liver, pancreas, and kidney; released into the blood; and taken up by cells via creatine transporters. In tissues with highly fluctuating demand for energy, such as muscle and brain, the creatine/phosphocreatine system serves as a temporal and spatial energy buffering system. Some of the abnormalities observed in GAMT deficiency can be explained by the deficiency of high-energy phosphate in such cells, while others appear to be related to the accumulation of guanidinoacetate.

  6. Oral supplementation of creatine in GAMT deficiency patients partially restores the creatine/phosphocreatine in brain and has beneficial effects on the clinical manifestations. The elevation of guanidinoacetate in plasma is largely refractory to oral supplementation of creatine, which may explain the persistence of some of the clinical symptoms.

Want access to your institution's subscription?

Sign in to your MyAccess Account while you are actively authenticated on this website via your institution (you will be able to tell by looking in the top right corner of any page – if you see your institution’s name, you are authenticated). You will then be able to access your institute’s content/subscription for 90 days from any location, after which you must repeat this process for continued access.

Ok

About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess account, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

OMMBID Full Site: One-Year Subscription

Connect to the full suite of OMMBID content including new and revised chapters that reflect the latest research, image galleries, clinical phenotypes, and more.

$295 USD
Buy Now

Pay Per View: Timed Access to all of OMMBID

24 Hour Subscription $34.95

Buy Now

48 Hour Subscription $54.95

Buy Now

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.